FDA approves ella™ tablets for prescription emergency contraception
Posted on 16. Aug, 2010 by admin in News-Pharmaceutical
The U.S. Food and Drug Administration today approved ella™ (ulipristal acetate) tablets for emergency contraception. The prescription-only product prevents pregnancy when taken orally within 120 hours (five days) after a contraceptive failure or unprotected intercourse. It is not intended for routine use as a contraceptive.
Nampak Cartons & Labels helps Yardley’s Oatmeal range care for more than the skin
Posted on 03. Aug, 2010 by admin in News-Pharmaceutical
As a leading curative and preventative skin care range, Yardley Oatmeal, produced by Indigo Cosmetics, is soft on the skin, and endorsed by leading dermatologists. Much like the contents it holds, It’s outer packaging or carton is also soft and caring, but on the environment rather than the skin.
How safe is the Pfizer dividend?
Posted on 05. May, 2010 by admin in Business-Financial Results, News-Pharmaceutical
Sean Riskowitz from asset management firm Manhattan Financial takes a look at whether the pharmaceutical giant can retain its dividend to shareholders: By Sean Riskowitz, Manhattan Financial The pharmaceutical industry has long been associated with strong dividends, large cash piles and cures for all mankind’s chronic ailments. The lure of annuity revenue streams protected by [...]
Basan South Africa established
Posted on 24. Apr, 2010 by admin in News-Pharmaceutical
The Basan group, a leading distributor of cleanroom products and services in Europe and Asia, has agreed to establish Basan South Africa. Basan has more than 25 years of experience in the cleanroom consumables and garment manufacturing business and has a worldwide network of well-known suppliers.
Sanofi-Aventis tops pharma dividend payers
Posted on 19. Apr, 2010 by admin in Business-Financial Results, News-Pharmaceutical
By: Sean Riskowitz of Manhattan Financial Investing in stocks that pay high dividends is an effective way for the conservative investor whose concern is mainly with the preservation of capital. When investing for a high dividend yield, the most important consideration for the investor is the sustainability of such dividends. Hence research into the underlying [...]
FDA phases out 7 metered-dose inhalers in US
Posted on 15. Apr, 2010 by admin in News-Pharmaceutical
The U.S. Food and Drug Administration today announced, in accordance with longstanding U.S. obligations under the Montreal Protocol on Substances that Deplete the Ozone Layer, seven metered-dose inhalers (MDI) used to treat asthma and chronic obstructive pulmonary disease (COPD) will be gradually removed from the U.S. marketplace. These inhalers contain ozone-depleting chlorofluorocarbons (CFCs), which are [...]
ISO/IEC standard to keep laboratory testers on their toes
Posted on 17. Mar, 2010 by admin in News-Pharmaceutical, Research
A new ISO/IEC standard establishes internationally harmonized requirements for verifying the competence of organizations that carry out proficiency testing of laboratories.
Vitabiotics partners with Clicks stores
Posted on 15. Mar, 2010 by admin in News-Pharmaceutical
Vitabiotics South Africa has partnered with Clicks stores as their preferred chain to stock Vitabiotics health products in the South Africa.
Indian Biotech firm seeks South African partners
Posted on 13. Mar, 2010 by admin in Business-Tenders, News-Pharmaceutical
Indian biotechnology firm Titan Biotech has approached ManufacturingHub.co.za to identify distributors for its products in South Africa.
BioScience turnaround on track
Posted on 11. Mar, 2010 by admin in Business-Financial Results, News-Pharmaceutical, Research
When AltX listed pharmaceutical and wellness stock Bioscience Brands was re-listed, we at ManufacturingHub.co.za were quite upbeat on its prospects. We retain this confidence in the overall offering.